Computer Aided Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others), By Application (Oncology, Cardiovascular Diseases, Neurological Disorders), By Company and By Region 2020-2030F

Market Overview

The Global Computer aided detection Market was valued at USD 912.53 Million in 2024 and is expected to reach USD 1309.88 Million by 2030 with a CAGR of 6.17% during the forecast period.  The global Computer-Aided Detection (CAD) market has gained significant traction as healthcare systems increasingly prioritize early and accurate diagnosis. CAD technologies assist radiologists and medical professionals in detecting abnormalities in medical images, improving diagnostic precision, and reducing human error. These systems are widely used across modalities such as mammography, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, with applications spanning oncology, cardiology, and pulmonary disease detection.

The market growth is largely driven by the rising prevalence of chronic diseases, particularly cancer, which necessitates early detection to improve patient outcomes. In addition, increasing adoption of advanced imaging technologies and the integration of artificial intelligence (AI) and deep learning into CAD systems have enhanced their diagnostic accuracy. AI-enabled CAD solutions offer faster and more reliable image analysis, allowing clinicians to identify conditions at earlier stages and support more effective treatment planning.

The global Computer-Aided Detection market is poised for sustained growth as healthcare providers adopt AI-driven technologies to improve diagnostic capabilities. With continuous advancements in imaging and analytical tools, CAD systems are set to play an increasingly vital role in improving patient outcomes and transforming modern healthcare delivery.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The global Computer-Aided Detection (CAD) market is witnessing significant growth, largely driven by the rising prevalence of chronic diseases across the world. Conditions such as cancer, cardiovascular disorders, diabetes, and respiratory illnesses are increasingly common due to aging populations, sedentary lifestyles, and environmental factors. Early and accurate detection of these chronic diseases is critical for improving patient outcomes, and CAD systems play a pivotal role in this process by assisting radiologists and clinicians in identifying anomalies in medical imaging more efficiently and reliably. The estimated cost of chronic disease is expected to reach $47 trillion worldwide by 2030. Individual lifestyle and behaviors and community factors play important roles in the development and management of chronic diseases. 

Technological advancements in artificial intelligence (AI) and machine learning are further fueling the adoption of CAD solutions. Modern CAD systems can analyze complex imaging data, detect subtle patterns, and reduce diagnostic errors, making them indispensable tools in hospitals, diagnostic centers, and research institutions. Additionally, the integration of CAD with advanced imaging modalities such as MRI, CT scans, and mammography is enhancing the precision and speed of disease detection, which is particularly valuable in screening programs for cancers and cardiovascular conditions.

The increasing burden of chronic diseases has also prompted governments and healthcare organizations to invest in digital health solutions. Policies promoting early detection, regular screenings, and preventive healthcare are encouraging healthcare providers to adopt CAD systems as part of routine diagnostic workflows. Moreover, the COVID-19 pandemic has highlighted the importance of remote and automated diagnostic solutions, further reinforcing the demand for computer-aided detection technologies. The global CAD market is expected to continue its robust growth as chronic diseases become more prevalent and healthcare systems increasingly rely on AI-driven tools to improve diagnostic accuracy, efficiency, and patient outcomes. The convergence of rising disease prevalence, technological innovation, and supportive healthcare policies is positioning CAD solutions as a critical component of modern medical diagnostics worldwide.

Focus on Preventive Healthcare and Early Diagnosis

The global Computer-Aided Detection (CAD) market is experiencing significant growth, largely driven by the increasing focus on preventive healthcare and early diagnosis. With healthcare systems worldwide emphasizing the importance of early disease detection, CAD technologies are gaining traction as vital tools that assist clinicians in identifying abnormalities at the earliest stages. These systems enhance diagnostic accuracy, reduce human error, and allow timely interventions, ultimately improving patient outcomes. Diseases such as cancer, cardiovascular disorders, and neurological conditions benefit greatly from early detection, reinforcing the demand for advanced CAD solutions.

Technological innovation is a key factor fueling the CAD market. Integration of artificial intelligence (AI) and machine learning (ML) into CAD systems has improved the precision and efficiency of detecting complex conditions from medical imaging data, such as mammograms, CT scans, and MRIs. AI-driven CAD solutions can analyze large volumes of imaging data rapidly, highlight suspicious areas, and assist radiologists in making informed decisions. The ability to provide automated, real-time analysis is particularly valuable in high-volume healthcare settings, reducing diagnostic workload and enabling faster clinical decisions.

Another factor driving innovation in the CAD market is the growing adoption of personalized and preventive medicine. Patients and healthcare providers are increasingly focused on proactive health management rather than reactive treatment. CAD systems play a critical role in this approach by identifying early-stage diseases before symptoms appear, allowing interventions that can prevent disease progression. Furthermore, rising awareness of preventive healthcare among patients, coupled with government initiatives promoting routine screening programs, is propelling the integration of CAD technologies in hospitals, diagnostic centers, and specialty clinics.

The COVID-19 pandemic also highlighted the importance of remote and automated diagnostic tools, accelerating research and development in CAD systems. Manufacturers are now focusing on creating more versatile, cloud-based, and user-friendly solutions that can be deployed across diverse clinical settings. This focus on innovation ensures that CAD systems continue to evolve, incorporating predictive analytics and advanced imaging algorithms to deliver higher diagnostic accuracy.

The global Computer-Aided Detection market is being propelled by a combination of technological advancements, the rising emphasis on preventive healthcare, and the growing need for early disease diagnosis. As healthcare stakeholders increasingly prioritize early intervention and efficient diagnostic solutions, CAD systems are poised to play a pivotal role in shaping the future of medical imaging and patient care.

Download Free Sample Report

Key Market Challenges

Lack of Standardization

Differences in imaging protocols, software platforms, and diagnostic approaches can lead to variability in results, impacting clinical confidence. This inconsistency creates reluctance among healthcare professionals to rely solely on CAD systems for diagnosis, as the risk of false positives or false negatives can have serious implications for patient care. Regulatory hurdles also pose a considerable challenge for the global CAD market. Approval processes for medical devices and diagnostic software vary across regions and can be lengthy and complex. Companies must comply with stringent regulations from authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), which can delay product launches and increase development costs.

Key Market Trends

Technological Advancements

The Global Computer-Aided Detection (CAD) Market is witnessing significant growth, largely fueled by rapid technological advancements in medical imaging and artificial intelligence. Innovations in machine learning algorithms, deep learning models, and cloud-based analytics are enabling CAD systems to deliver more accurate and faster detection of diseases such as cancer, cardiovascular conditions, and neurological disorders. This has enhanced the confidence of radiologists and clinicians, reducing diagnostic errors and improving patient outcomes.

Integration of advanced imaging modalities, such as 3D mammography, MRI, and CT scans, with CAD solutions has further strengthened market adoption. These technologies allow CAD systems to analyze complex datasets with higher precision, facilitating early diagnosis and personalized treatment planning. Moreover, the development of real-time detection systems and automated reporting tools has improved workflow efficiency in hospitals and diagnostic centers, making CAD a critical tool in modern healthcare.

Additionally, the increasing focus on AI-powered healthcare solutions and the adoption of cloud computing platforms have expanded the reach of CAD technologies across remote and underserved regions. For instance, in 2020, a study in work with data sets from the U.S. and the United Kingdom (U.K.) revealed that the AI model was able to successfully screen for breast cancer using only the pixel data given. The ability to store, share, and analyze large volumes of imaging data has accelerated research and innovation, driving continuous improvements in detection accuracy. Collaboration between technology providers, healthcare institutions, and research organizations is further fueling the development of next-generation CAD solutions, emphasizing predictive analytics and early disease prevention. Technological advancements are at the heart of the global CAD market’s growth, enabling enhanced diagnostic capabilities, operational efficiency, and patient care. As innovation continues to evolve, the market is expected to witness further expansion, with CAD systems becoming an indispensable component of modern diagnostic workflows worldwide.

Segmental Insights

Modality Insights

Based on the modality, the Mammography segment has emerged as the fastest-growing segment in the Global Computer aided detection Market in 2024, due to several key factors. Firstly, the increasing prevalence of breast cancer globally has led to heightened awareness and routine screening programs, particularly in developed countries, driving demand for mammography-based CAD solutions. Secondly, advancements in digital mammography, including 3D tomosynthesis and AI-enabled detection, have improved diagnostic accuracy, early detection rates, and workflow efficiency, encouraging adoption among healthcare providers. Additionally, government initiatives and reimbursement policies supporting breast cancer screening further stimulate the use of mammography CAD systems. Overall, the combination of rising disease incidence, technological innovations, and supportive healthcare policies is propelling the growth of this segment.

Application Insights

Based on application, the oncology segment has emerged as the fastest-growing segment in the Global Computer aided detection Market in 2024 due to the increasing global incidence of cancer and the critical need for early and accurate diagnosis. CAD systems significantly enhance the detection of tumors in imaging modalities such as mammography, CT scans, and MRI, enabling radiologists to identify malignancies at an earlier stage. According to WHO, there is a probability of a 30% rise in the number of cancer cases by 2038.  Rising awareness of cancer screening programs, advancements in imaging technologies, and the integration of artificial intelligence to improve diagnostic accuracy have further fueled adoption in oncology. Additionally, government initiatives and private investments in cancer care infrastructure across emerging and developed markets are driving strong demand for CAD solutions in oncology applications.

Top of Form

Download Free Sample Report

Regional Insights

North America emerged as the largest region in the Global Computer aided detection Market in 2024, driven by several key factors. The region’s advanced healthcare infrastructure, including widespread access to state-of-the-art diagnostic imaging facilities, enables rapid adoption of CAD technologies, particularly in radiology and oncology. High volumes of imaging procedures, fueled by the prevalence of chronic diseases such as cancer and cardiovascular conditions, further create demand for CAD systems that enhance accuracy and efficiency. According to the CDC, in the U.S., roughly 210,828 people were detected with lung cancer, including 99,433 women and 111,395 men. Also, in the U.S., 157,423 people died from lung cancer. Strong research and development investments have led to continuous innovation, including AI-enhanced imaging algorithms and integration with Picture Archiving and Communication Systems (PACS), accelerating adoption across healthcare providers. Additionally, supportive regulatory frameworks, including U.S. Food and Drug Administration (FDA) approvals, ensure safety and efficacy, fostering trust among clinicians and patients.

Recent Development

• In April 2025, RadNet, a leading diagnostic imaging provider, announced an all-stock acquisition of iCAD, a leader in breast-health AI, valuing the transaction at approximately USD 103 million. This strategic merger is designed to accelerate RadNet’s AI-driven breast cancer screening and diagnostic capabilities by integrating iCAD’s ProFound Breast Health Suite into its DeepHealth portfolio.
• In March 2025, iCAD entered a strategic partnership with RamSoft to embed its ProFound AI Breast Health Suite within RamSoft’s RIS/PACS platform across North America. The integration, initially implemented at Mammolink and expanding to over 750 imaging sites, is expected to enhance workflow efficiency and improve breast cancer detection rates.
• Also in March 2025, at the European Congress of Radiology (ECR) 2025, iCAD showcased clinical performance and new real-world data for its ProFound AI Breast Health Suite. The presentation highlighted AI-powered modules for detection, density assessment, and risk evaluation, building on more than 20 years of breast-health innovation.
• In March 2022, EDDA Technology formalized a collaboration with the Society of Interventional Oncology (SIO) for the ACCLAIM trial, a study evaluating microwave ablation with real-time 3D margin assessment for colorectal liver metastases. EDDA’s IQQA-BodyImaging software is being used to ensure precise ablation margins during procedures.

Key Market Players

• Hologic Inc.
• GE Healthcare Technologies Inc.
• Agfa-Gevaert N.V
• iCAD, Inc.
• Invivo Corporation
• McKesson Corporation
• Siemens Healthineers AG
• EDDA technology, Inc.
• FUJIFILM Medical Systems U.S.A., Inc.
• Koninklijke Philips N.V.

Report Scope

In this report, global computer aided detection market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Computer Aided Detection Market, By Imaging Modality:

o   Mammography

o   MRI

o   Ultrasound

o   Tomosynthesis

o   Others

·         Computer Aided Detection Market, By Application:

o    Oncology

§  Breast Cancer

§  Lung Cancer

§  Colorectal Cancer

§  Prostate Cancer

§  Others

o    Cardiovascular Diseases

o    Neurological Disorders

·         Computer Aided Detection Market, By Region:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• Europe 
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in computer aided detection market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).